Table 1.
Characteristics of global treatment guidelines for depressive disorder
| Organization | Publication year | Audience | Methodology |
|---|---|---|---|
| Korean Medication Algorithm Project for Depressive Disorder 2021 | 2021 | Psychiatrists | Expert consensus |
| World Federation of Societies of Biological Psychiatry Guide-lines for Biological Treatment of Unipolar Depressive Disorders | 2013 (acute and continuation treatment) 2015 (maintenance treatment) |
Psychiatrists, Primary-care physicians |
Evidence-based |
| British Association for Psychopharmacology Guidelines | 2015 | All doctors (usually primary care physicians) | Evidence-based |
| Canadian Network for Mood and Anxiety Treatments Clinical Guidelines for the Management of Major Depressive Disorders | 2016 | Psychiatrists | Evidence-based |
| Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for Mood Disorders: Major Depression | 2020 | Psychiatrists, psychologists, and primary-care physicians |
Evidence-based and expert consensus-based |